Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

Texas Lawmaker Named BIO State Legislator of the Year
Mar 6 2000
Dallas, Texas (March 6, 2000) The Biotechnology Industry Organization (BIO) has named Texas Rep. Brian McCall (R-Plano) as BIO State Legislator of the Year...
Environmental, Industrial and Agricultural Applications Of Biotechnology Featured At BIO 2000
Mar 1 2000
WASHINGTON, D.C. (March 1, 2000) In addition to health care, biotechnology's impact on the environment, industrial manufacturing and agriculture will be...
BIO 2000 Internet News Room Provides Up-To-The-Minute Conference Information
Feb 29 2000
WASHINGTON, D.C. (February 29, 2000) -- The Biotechnology Industry Organization (BIO) has placed on its website (www.bio.org) a BIO 2000 News Room to provide...
BIO 2000 Examines Advances In Genomics, Gene Therapy
Feb 25 2000
WASHINGTON, D.C. (February 25, 2000) Genomics has captured the attention of Wall Street investors and the imagination of others worldwide as researchers near...
BIO Opposes Mandatory Labeling Bill Introduced by Sen. Boxer
Feb 23 2000
WASHINGTON, D.C. (February 23, 2000) The BiotechnologyIndustry Organization (BIO) issued the following statement in response to the bill introduced by U.S....
BIO's Comments Regarding Proposed Standards For The Privacy of Individually Identifiable Health Information
Feb 17 2000
EXECUTIVE SUMMARY BIO represents over 850 biotechnology companies, academic institutions, state biotechnology centers, and related organizations in 46 states...
Christopher Reeve Among Speakers at BIO 2000
Feb 14 2000
WASHINGTON, D.C. (February 14, 2000) - Christopher Reeve, paralyzed five years ago after a fall during an equestrian competition, will discuss his life and...
Price Controls Will Hurt Patients, Biotech Innovation
Feb 10 2000
WASHINGTON, D.C. (February 11, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement concerning a...
BIO Fully Supports President's Ban On Genetic Discrimination
Feb 8 2000
WASHINGTON, D.C. (February 8, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today on...
BIO Responds To President Clinton's State Of The Union Speech
Jan 27 2000
WASHINGTON, D.C. (Jan. 27, 2000) Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement on Medicare...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...